Advertisement
Advertisement
U.S. markets open in 56 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Jeil Pharmaceutical Co.,Ltd (271980.KS)

KSE - KSE Delayed Price. Currency in KRW
18,900.00-100.00 (-0.53%)
At close: 03:30PM KST
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
723,808,871
700,693,229
691,324,837
671,406,875
627,074,758
Cost of Revenue
565,930,038
544,716,840
534,633,671
519,483,226
488,442,689
Gross Profit
157,878,833
155,976,389
156,691,166
151,923,649
138,632,069
Operating Expense
172,496,497
166,356,294
143,786,793
151,548,539
131,241,995
Operating Income
-14,617,664
-10,379,905
12,904,373
375,110
7,390,074
Net Non Operating Interest Income Expense
-3,039,062
-1,891,091
-996,224
-1,079,047
-1,586,125
Pretax Income
-24,444,253
-13,833,971
12,551,990
-940,857
4,888,448
Tax Provision
87,651
1,151,646
5,587,188
9,643,736
2,999,415
Net Income Common Stockholders
-20,556,490
-12,473,279
6,916,121
-10,584,593
1,889,033
Basic EPS
-
-854.00
473.00
-721.00
142.00
Diluted EPS
-
-854.00
473.00
-721.00
142.00
Basic Average Shares
-
14,609
14,614
14,675
13,342
Diluted Average Shares
-
14,609
14,614
14,675
13,342
Total Operating Income as Reported
-14,789,805
-10,530,151
12,904,373
375,109
7,390,074
Rent Expense Supplemental
-
-
-
-
1,506,881
Total Expenses
738,426,535
711,073,134
678,420,464
671,031,765
619,684,684
Net Income from Continuing & Discontinued Operation
-20,556,490
-12,473,279
6,916,121
-10,584,593
1,889,033
Normalized Income
-16,725,749
-7,799,750
7,287,114
-9,995,881
1,820,888
Interest Income
97,428
75,841
75,272
135,841
10,671
Interest Expense
3,136,489
1,966,932
1,071,496
1,214,888
1,596,797
Net Interest Income
-3,039,062
-1,891,091
-996,224
-1,079,047
-1,586,125
EBIT
-21,307,764
-11,867,039
13,623,486
274,031
6,485,245
EBITDA
-12,418,246
-
-
-
-
Reconciled Cost of Revenue
565,930,038
544,716,840
534,633,671
519,483,226
488,442,689
Reconciled Depreciation
8,889,518
9,132,602
8,992,862
7,605,968
6,625,367
Net Income from Continuing Operation Net Minority Interest
-20,556,490
-12,473,279
6,916,121
-10,584,593
1,889,033
Total Unusual Items Excluding Goodwill
-6,384,569
-6,231,371
-494,657
-784,950
90,859
Total Unusual Items
-6,384,569
-6,231,371
-494,657
-784,950
90,859
Normalized EBITDA
-6,033,677
3,496,934
23,111,005
8,664,949
13,019,753
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,553,828
-1,557,843
-123,664
-196,237
22,715
Advertisement
Advertisement